GW Pharma's cannabis-based drug appears poised for a groundbreaking FDA approval as internal review offers a clear thumbs up
GW Pharmaceuticals’ $GWPH lead drug picked up a clear endorsement from regulators at the FDA this morning.
In the agency’s internal review of GW …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
